News
One company that enterprises are scrambling to partner with is data analytics specialist Palantir (PLTR). Palantir already ...
NEW YORK (Reuters) -Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, ...
Palantir shares rebounded to post gains Monday as the tech company said it was partnering with Accenture for its work with ...
Palantir (NASDAQ: PLTR) and Nuclear Company will jointly create the nuclear operating system (NOS), which will simplify ...
The company is securing more contracts under the Trump administration, and there seems to be rising investor confidence that ...
NEW YORK (Reuters) -A meteoric rally in shares of Palantir Technologies (NASDAQ: PLTR) is likely to leave its imprint on the ...
According to the Forrester Consulting study, AI is delivering 13–37% gains in areas like claim accuracy, payment speed, and workforce efficiency. With 82% of healthcare leaders calling AI essential to ...
Even a substantial and ongoing investment into the stock will struggle to turn into $1 million in 15 years. For example, if ...
Wall Street's consensus price target for PLTR is $101, with a high of $155. One analyst has a price target of $40. That reflects how wildly divided analysts are on what Palantir's true value is.
Key to the innovation is a deep-learning reconstruction engine that enhances detail and enables exploratory insights across oncology, cardiology, and neurology. GE HealthCare sees the platform as a ...
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the 10 software stocks analysts are upgrading. On June 12, Loop Capital analyst Mark Schappel upped the price objective on the company’s stock ...
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best stocks to buy. An SEC filing revealed that Palantir director, Eric H. Woersching, sold nearly $2.2 million worth of his shares on June 10.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results